These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9290733)

  • 21. [Chronic transplant damages: unsatisfactory long-term results of organ transplantation].
    Tullius SG; Bechstein WO; Neuhaus P
    Dtsch Med Wochenschr; 1995 Dec; 120(51-52):1791-6. PubMed ID: 8549266
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of IL-4 and Th2 responses in allograft rejection and tolerance.
    Tay SS; Plain KM; Bishop GA
    Curr Opin Organ Transplant; 2009 Feb; 14(1):16-22. PubMed ID: 19337141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelium and regulatory inflammatory mechanisms during organ rejection.
    Taccone FS; Crimi E; Anstey J; Infante T; Donadello K; Scolletta S; Al-Omran M; Napoli C
    Angiology; 2014 May; 65(5):379-87. PubMed ID: 23636852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The divergent roles of macrophages in solid organ transplantation.
    Salehi S; Reed EF
    Curr Opin Organ Transplant; 2015 Aug; 20(4):446-53. PubMed ID: 26154913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
    Shears LL; Kawaharada N; Tzeng E; Billiar TR; Watkins SC; Kovesdi I; Lizonova A; Pham SM
    J Clin Invest; 1997 Oct; 100(8):2035-42. PubMed ID: 9329968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.
    Utans U; Arceci RJ; Yamashita Y; Russell ME
    J Clin Invest; 1995 Jun; 95(6):2954-62. PubMed ID: 7769138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of complement in graft rejection after organ transplantation.
    Bos IG; Ten Berge IJ; Hack CE
    Transfus Med Rev; 2002 Jul; 16(3):251-64. PubMed ID: 12075562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection-associated macrophage activation accelerates chronic renal allograft rejection in rats.
    Nagano H; Nadeau KC; Kusaka M; Heeman UW; Tilney NL
    Transplantation; 1997 Dec; 64(11):1602-5. PubMed ID: 9415565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation.
    Davidson C; Verma ND; Robinson CM; Plain KM; Tran GT; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2007 Apr; 17(3):178-86. PubMed ID: 17331844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction.
    Orloff MS; DeMara EM; Coppage ML; Leong N; Fallon MA; Sickel J; Zuo XJ; Prehn J; Jordan SC
    Transplantation; 1995 Jan; 59(2):282-8. PubMed ID: 7839452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement in organ transplantation. Contributions to inflammation, injury, and rejection.
    Baldwin WM; Pruitt SK; Brauer RB; Daha MR; Sanfilippo F
    Transplantation; 1995 Mar; 59(6):797-808. PubMed ID: 7701572
    [No Abstract]   [Full Text] [Related]  

  • 32. Activated macrophages require T cells for xenograft rejection under the kidney capsule.
    Zhan Y; Brady JL; Irawaty W; Thomas HE; Kay TW; Lew AM
    Immunol Cell Biol; 2003 Dec; 81(6):451-8. PubMed ID: 14636242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
    Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
    Transplantation; 1995 Jun; 59(12):1647-53. PubMed ID: 7604433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer.
    Yi S; Wang Y; Chandra AP; O'Hara JM; Wu J; Ouyang L; Burgess JS; Hawthorne W; Wu H; Chadban SJ; O'Connell PJ
    Transplantation; 2007 Mar; 83(5):615-23. PubMed ID: 17353783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of chronic rejection of renal allografts in rats using a synthetic inhibitor of macrophage effector activation.
    Ishibashi M; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):564-5. PubMed ID: 7879100
    [No Abstract]   [Full Text] [Related]  

  • 36. Intragraft cellular events associated with tolerance in pig allografts: the "acceptance reaction".
    Shimizu A; Yamada K; Meehan SM; Sachs DH; Colvin RB
    Transplant Proc; 1997; 29(1-2):1155. PubMed ID: 9123247
    [No Abstract]   [Full Text] [Related]  

  • 37. Murine model of accelerated graft arteriosclerosis in primed recipients.
    Li S; Fu F; DeLeo J; Hoover J; Lake P; Shi V
    Transplant Proc; 2001; 33(1-2):405. PubMed ID: 11266884
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes.
    Hancock WW; Buelow R; Sayegh MH; Turka LA
    Nat Med; 1998 Dec; 4(12):1392-6. PubMed ID: 9846576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between islet xenograft rejection mediated by activated macrophages and upregulated chemokines.
    Chandra AP; Ou-Yang L; Wong JK; Ha H; Walters SN; Patel AT; Hawthorne WJ; Yi SN
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):26-35. PubMed ID: 17344583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The increasing complexity of understanding rejection.
    Hall BM
    Curr Opin Organ Transplant; 2009 Feb; 14(1):1-3. PubMed ID: 19337138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.